Search results :

Lantus

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: A10AE04

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7
Hypoglycaemia 25.5% - 33% x x x x x x x
Oedema peripheral 1.79% - 22.7% x x x x
Hypertension 18.9% - 19.6% x x x
Influenza 18.7% - 19.5% x x x x
Upper respiratory tract infection 11.4% - 33.6% x x x x x
Sinusitis 3.23% - 18.5% x x x x x
Cataract 15.9% - 18.1% x x x
Arthralgia 14.2% - 16.1% x x x
Bronchitis 14.1% - 15.2% x x x x
Pain in extremity 13% - 13.1% x x x x
Back pain 2.69% - 12.8% x x x x
Diarrhoea 10.3% - 10.7% x x x x
Infection 8.64% - 17.7% x x x x x
Depression 9.7% - 10.5% x x x
Urinary tract infection 1.95% - 10.7% x x x x
Cough 7.4% - 12.1% x x x
Pharyngitis 7.5% - 8.6% x x x x
Retinal vascular disorder 3.89% - 7.4% x x x x
Neoplasm malignant 3.02% - 8.53% x
Accidental injury 4.8% - 6.4% x x x x x
Headache 4.15% - 10.3% x x x x x
Rhinitis 2.9% - 5.2% x x x x x
Injection site haemorrhage 4.23% - 4.54% x x
Gastroenteritis 3.23% - 3.59% x x
Hypoglycemic reaction 2.56% - 3.42% x x
Neuropathy 2.52% x
Injection site pain 0.729% - 2.61% x x x x x x
Abdominal pain x
Anaphylactic shock x x x
Angioedema x x x x x
Asthma x
Background diabetic retinopathy x x x
Benign neoplasm of skin x
Bone disorder x
Bronchospasm x x x x x
Coma x
Connective tissue disorder x
Fungal skin infection x
Dysgeusia x
Eczema x
Oedema x x x x x
Rash x x x
Fracture x
Glycosuria x x x
Cardiac failure x
Herpes zoster x
Hypernatraemia x x x x x
Hypersensitivity x x x x x x x
Hypotension x x x x x
Immune system disorder x
Inflammation x x x x x
Ketosis x
Lipodystrophy x x x x x x x
Myocardial infarction x
Nervous system disorder x
Pain x x x x x
Neuropathy peripheral x x x
Pruritus x x x x x x x
Refraction disorder x x x
Retinal disorder x x x x x x x
Shock x x x x x
Cerebrovascular accident x
Swelling x x
Loss of consciousness x
Urticaria x x x x x x
Weight increased x x x
Injection site reaction x x x x x x x
Injection site mass x
Malnutrition x x
Unspecified disorder of skin and subcutaneous tissue x
Myalgia x
Throat sore x
Glucose tolerance impaired x
Redness x x x x x
Neuroglycopenia x
Amaurosis x x
Application site pain x x x x
Cough increased x
Blood glucose abnormal x
Hypoglycaemic episode x
Worsening of diabetes x x x x x x
Lipohypertrophy x x x x
Impaired fasting glucose x
Lipoatrophy x x x x
Blindness, both eyes x
Visual impairment x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

INSULIN GLARGINE RECOMBINANT / LANTUS

Side effects:9
Source:FDA

INSULIN GLARGINE / LANTUS -(VIAL)

Side effects:41
Source:Health Canada

insulin glargine / insulin glargine

Side effects:32
Source:EMA

Lantus

Side effects:35
Source:medicines.org.au

INSULIN GLARGINE

Side effects:47
Source:FDA Structured Product Label

INSULIN GLARGINE

Side effects:49
Source:FDA Structured Product Label

insulin glargine

Side effects:52
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label